JO
BOLD

John Overdeck’s Boundless Bio BOLD Stock Holding History

John Overdeck’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,808
Closed -$40K – 3540
2024
Q4 		$40K Sell
13,808
-13,052
-49% -$38K ﹤0.01% 3063
2024
Q3 		$93.2K Sell
26,860
-1,756
-6% -$6.36K ﹤0.01% 2908
2024
Q2 		$111K Buy
28,616
+11,616
+68% +$111K ﹤0.01% 2812
2024
Q1 		$242K Buy
+17,000
New +$242K ﹤0.01% 2641

Other funds holding BOLD

Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

John Overdeck's BOLD Position: Q1 2025 in Review

John Overdeck sold out of Boundless Bio (BOLD) in Q1 2025, closing a stake of 13,808 shares — an estimated $40K sold.

John Overdeck first reported a position in BOLD in Q1 2024 and held it in 4 quarters. The position peaked at $242K in Q1 2024. 54 funds tracked by Wall St. Rank hold BOLD as of Q1 2025.

  • John Overdeck reported no remaining Boundless Bio position as of Q1 2025 after selling out during the quarter.
  • John Overdeck sold 13,808 Boundless Bio shares in Q1 2025, an estimated $40K.
  • John Overdeck first reported a position in Boundless Bio in Q1 2024 and held it in 4 quarters.
  • John Overdeck's Boundless Bio position peaked at $242K in Q1 2024.
  • 54 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2025.

Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.